Literature DB >> 2523215

Qualitative analyses of cellular immune functions in equine infectious anemia show homology with AIDS.

M Gerencer1, I Valpotić, B Jukić, M Tomasković, I Basić.   

Abstract

Equine infectious anemia (EIA) is a disease caused by a lymphocytotropic lentivirus which belongs to the same subfamily as HIV. Because of the very close relationship of their predicted gag and pol gene products and similarities in clinical manifestations of the disease, EIA served as a model to study immunological events involved in the host defence against lymphocytotropic viral infections. The existence of antibody dependent cell-mediated cytotoxicity against autologous EIA virus infected lymphoblasts was demonstrated in vitro at the beginning of an acute attack of the disease. Cytotoxic activity was not found or was very low during chronic infection. Reactivity of peripheral blood lymphocytes to Protein A and allogeneic cells in vitro was significantly suppressed in the presence of an acute serum, while the reactivity to PHA was at the normal level. These results suggest that cellular immune mechanism(s) are also involved in removal of EIA virus infected cells as has been reported recently in HIV-1 infected individuals and that EIAV and HIV immunopathogenesis show similarities in affecting the immune response of the host.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2523215     DOI: 10.1007/bf01315547

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  26 in total

1.  Lentivirus genomic organization: the complete nucleotide sequence of the env gene region of equine infectious anemia virus.

Authors:  K Rushlow; K Olsen; G Stiegler; S L Payne; R C Montelaro; C J Issel
Journal:  Virology       Date:  1986-12       Impact factor: 3.616

Review 2.  Current concepts in the immunopathogenesis of AIDS and HIV infection.

Authors:  L J Eales; J M Parkin
Journal:  Br Med Bull       Date:  1988-01       Impact factor: 4.291

3.  Detection of antibodies which mediate human immunodeficiency virus-specific cellular cytotoxicity (ADCC) in vitro.

Authors:  K Ljunggren; E M Fenyö; G Biberfeld; M Jondal
Journal:  J Immunol Methods       Date:  1987-11-23       Impact factor: 2.303

Review 4.  The CD4 antigen: physiological ligand and HIV receptor.

Authors:  Q J Sattentau; R A Weiss
Journal:  Cell       Date:  1988-03-11       Impact factor: 41.582

Review 5.  Equine infectious anemia virus: immunopathogenesis and persistence.

Authors:  W P Cheevers; T C McGuire
Journal:  Rev Infect Dis       Date:  1985 Jan-Feb

6.  Equine infectious anemia virus gag and pol genes: relatedness to visna and AIDS virus.

Authors:  R M Stephens; J W Casey; N R Rice
Journal:  Science       Date:  1986-02-07       Impact factor: 47.728

7.  Antibody-dependent cell-mediated cytotoxicity against cells infected with the human immunodeficiency virus.

Authors:  R S Blumberg; T Paradis; K L Hartshorn; M Vogt; D D Ho; M S Hirsch; J Leban; V L Sato; R T Schooley
Journal:  J Infect Dis       Date:  1987-12       Impact factor: 5.226

8.  HIV-specific cytotoxic T lymphocytes in seropositive individuals.

Authors:  B D Walker; S Chakrabarti; B Moss; T J Paradis; T Flynn; A G Durno; R S Blumberg; J C Kaplan; M S Hirsch; R T Schooley
Journal:  Nature       Date:  1987 Jul 23-29       Impact factor: 49.962

9.  Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals.

Authors:  K J Weinhold; H K Lyerly; T J Matthews; D S Tyler; P M Ahearne; K C Stine; A J Langlois; D T Durack; D P Bolognesi
Journal:  Lancet       Date:  1988-04-23       Impact factor: 79.321

10.  Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen).

Authors:  L L Lanier; T J Kipps; J H Phillips
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

View more
  7 in total

1.  Characterization of the antigenic domains of the major core protein (p26) of equine infectious anemia virus.

Authors:  Y H Chong; S L Payne; C J Issel; R C Montelaro; K E Rushlow
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

2.  Gag protein epitopes recognized by CD4(+) T-helper lymphocytes from equine infectious anemia virus-infected carrier horses.

Authors:  S M Lonning; W Zhang; T C McGuire
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  Detection and induction of equine infectious anemia virus-specific cytotoxic T-lymphocyte responses by use of recombinant retroviral vectors.

Authors:  S M Lonning; W Zhang; S R Leib; T C McGuire
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

4.  Major histocompatibility complex-restricted CD8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins.

Authors:  T C McGuire; D B Tumas; K M Byrne; M T Hines; S R Leib; A L Brassfield; K I O'Rourke; L E Perryman
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

5.  Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.

Authors:  Laryssa Howe; Caroline Leroux; Charles J Issel; Ronald C Montelaro
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

6.  Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus.

Authors:  C J Issel; D W Horohov; D F Lea; W V Adams; S D Hagius; J M McManus; A C Allison; R C Montelaro
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

Review 7.  The immunopathogenesis of equine infectious anemia virus.

Authors:  D C Sellon; F J Fuller; T C McGuire
Journal:  Virus Res       Date:  1994-05       Impact factor: 3.303

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.